- Medicina i Cirurgia
Departament
![Foto de Jesús](/img/nophoto.png)
Jesús
Egido de los Ríos
Publications dans lesquelles il/elle collabore avec Jesús Egido de los Ríos (9)
2021
-
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257
2020
-
IL‐17A as a potential therapeutic target for patients on peritoneal dialysis
Biomolecules, Vol. 10, Núm. 10, pp. 1-36
2018
-
Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease
Atherosclerosis, Vol. 270, pp. 13-20
2017
-
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease
Atherosclerosis, Vol. 260, pp. 130-137
2016
-
Soluble TWEAK and major adverse cardiovascular events in patients with CKD
Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 3, pp. 413-422
2015
-
Paricalcitol inhibits aldosterone-induced proinflammatory factors by modulating epidermal growth factor receptor pathway in cultured tubular epithelial cells
BioMed Research International, Vol. 2015
-
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
Atherosclerosis, Vol. 239, Núm. 2, pp. 358-363
2013
-
Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease
Journal of Nephrology, Vol. 26, Núm. 6, pp. 1105-1113
2011
-
Globotriaosylsphingosine actions on human glomerular podocytes: Implications for Fabry nephropathy
Nephrology Dialysis Transplantation, Vol. 26, Núm. 6, pp. 1797-1802